D.B.P. Distribution is recalling Titanium 4000 (4000 mg) capsules because they contain undeclared sildenafil and tadalafil, which are the active ingredients in FDA-approved prescription drugs for erectile dysfunction. These undeclared drug ingredients can interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. The recalled product was sold nationwide in single-count blister cards within 30-count display boxes and is marked with an expiration date of 12/29/2020. Consumers should contact their healthcare provider or pharmacist for guidance regarding this product.
The product contains hidden drug ingredients, sildenafil and tadalafil, which can pose a significant health risk to consumers with underlying medical conditions, such as diabetes, high blood pressure, or heart disease. Specifically, these ingredients can interact with nitrates used in common heart medications, causing a life-threatening drop in blood pressure.
Contact healthcare provider and return product for refund.
“Front of Package, Titanium 4000 capsules”
“Back of package, Titanium 4000 capsules”
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.